Lockdowns have rekindled bullishness in FMCG and pharma stocks with companies expected to report exceptional sales in the short term. The ET Pharma Index has gained 5.3 per cent in the past one month with a price-to-earnings (PE) multiple of 33.4.
https://ift.tt/3swuxHb
0 Comments